Skip to main content
Premium Trial:

Request an Annual Quote

Novartis Crop Protection And Acacia Strike Deal


RICHMOND, Calif.--Acacia Biosciences here and Novartis Crop Protection announced the signing of a profiling agreement to utilize Acacia's patented Genome Reporter Matrix to aid in the selection and optimization of lead compounds for crop-protection products. Under the agreement, Acacia will provide chemical and biological profiles on a class of Novartis's compounds for an undisclosed fee.

The patented technology incorporates a microarray that measures changes in gene expression with a comprehensive database of expression profiles and a set of software tools that facilitate the comparison of profiles and the discovery of new genes and targets. Acacia said the first generation of this technology is based on the fully sequenced yeast genome.

Filed under

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.